Exelixis (EXEL) Stock: Buy, Sell, or Hold?
$69.96
-0.75 (-1.05%)
▼
5d:
+1.81%
30d:
+14.7%
90d:
+36.52%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 29, 2026
0d
Protect EXEL Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (18%)
Quality Score
27/100
Position
EXTENDED
30-Day Fair Range
$60.60 – $69.77
Position: EXTENDED
Forward P/E & Valuation
16.5x
STRETCHED
vs 12.9x historical avg
Wall Street Target
$61.57
-12.9% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$67.05 / $73.69
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: EXEL shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When EXEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$84.62
Based on 9.0% avg growth
INTRINSIC VALUE TODAY
$52.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EXEL is currently trading at $69.95, which is considered extended relative to its 30-day fair value range of $60.60 to $69.77. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.5) compared to its historical average (12.9). At these levels, the market is pricing in 8.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EXEL is in a strong uptrend. Immediate support is located at $67.05, while resistance sits at $73.69.
Market Sentiment: EXEL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $61.57. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EXEL is in a strong uptrend. Immediate support is located at $67.05, while resistance sits at $73.69.
Market Sentiment: EXEL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $61.57. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$60.60 -
$69.77
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
18.1%
Trading Range & Key Levels
30-Day Trading Range
$60.60 -
$69.77
Current vs Trading Range
EXTENDED
Support Level
$67.05
Resistance Level
$73.69
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding EXEL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 12.9% above Wall St target ($61.57)
- NEUTRAL: Trading at premium valuation - market expects 8.7% growth which is achievable
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
16.54
Wall Street Target
$61.57
(-12.9%)
Revenue Growth (YoY)
10.2%
Earnings Growth (YoY)
23.2%
Profit Margin
35.4%
Valuation Premium vs History
+8.7% premium
PE vs Historical
16.5 vs 12.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.7%
(market-implied from PE analysis)
1-Year Target
$76.85
(+9%)
2-Year Target
$83.54
(+18%)
3-Year Target
$90.80
(+28%)
3-Yr Target (if PE normalizes)
(PE: 17→13)
PE COMPRESSION
$70.82
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 14.0%)
$125.60
(+78%)
Base:
(SPY PE: 16.5, Growth: 14.0%)
$104.61
(+48%)
Bear:
(PE: 12.9, Growth: 14.0%)
$81.59
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 21.13 | Current EPS (TTM): $3.34
Bull Case
$99.36
(+41%)
Analyst growth 28.0%, PE expands to 23.2
Base Case
$90.33
(+28%)
Market implied 28.0%, PE stable at 21.1
Bear Case
$47.99
(-32%)
Severe decline -20.0%, PE contracts to 18.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share EXEL Analysis
Share this live EXEL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (EXEL)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 2, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate a bullish outlook on $EXEL and related stocks $PG, $REPL, $CL, and $KMB, as traders believe the industry is pivoting towards basic necessities and health. No recent Yahoo Finance news articles were available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:51 PM ET
Data refreshes hourly during market hours. Next update: 2:51 PM
Data refreshes hourly during market hours. Next update: 2:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EXEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Advanced EXEL Option Strategies
Professional options setups generated by AI based on today's EXEL price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive EXEL Research Pages
